Tatsushi Kawada

1.4k total citations
64 papers, 433 citations indexed

About

Tatsushi Kawada is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Tatsushi Kawada has authored 64 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 32 papers in Surgery and 16 papers in Urology. Recurrent topics in Tatsushi Kawada's work include Bladder and Urothelial Cancer Treatments (28 papers), Urinary and Genital Oncology Studies (23 papers) and Renal cell carcinoma treatment (15 papers). Tatsushi Kawada is often cited by papers focused on Bladder and Urothelial Cancer Treatments (28 papers), Urinary and Genital Oncology Studies (23 papers) and Renal cell carcinoma treatment (15 papers). Tatsushi Kawada collaborates with scholars based in Japan, Austria and United States. Tatsushi Kawada's co-authors include Shahrokh F. Shariat, Takafumi Yanagisawa, Paweł Rajwa, Benjamin Pradère, Fahad Quhal, Ekaterina Laukhtina, Maximilian Pallauf, Takahiro Kimura, Reza Sari Motlagh and Hadi Mostafaei and has published in prestigious journals such as The Journal of Urology, International Journal of Cancer and European Urology.

In The Last Decade

Tatsushi Kawada

54 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tatsushi Kawada Japan 12 269 183 82 76 62 64 433
Giulia Primiceri Italy 13 263 1.0× 322 1.8× 129 1.6× 58 0.8× 58 0.9× 21 571
Luis Kluth Germany 15 240 0.9× 331 1.8× 113 1.4× 152 2.0× 24 0.4× 53 632
Rubén Olivares Chile 13 147 0.5× 115 0.6× 103 1.3× 41 0.5× 25 0.4× 33 383
Matthew D. Katz United States 9 294 1.1× 248 1.4× 86 1.0× 125 1.6× 43 0.7× 19 506
Sabina Sevcenco Austria 13 297 1.1× 126 0.7× 63 0.8× 147 1.9× 187 3.0× 39 512
Justine Varinot France 14 175 0.7× 388 2.1× 112 1.4× 104 1.4× 39 0.6× 39 619
Satoshi Nagamori Japan 12 222 0.8× 228 1.2× 72 0.9× 81 1.1× 20 0.3× 38 424
J. Lam United States 5 587 2.2× 209 1.1× 68 0.8× 316 4.2× 70 1.1× 7 671
Yu‐Ching Wei Taiwan 11 127 0.5× 233 1.3× 105 1.3× 117 1.5× 10 0.2× 33 454
Alexandre Crippa Brazil 10 229 0.9× 166 0.9× 114 1.4× 133 1.8× 19 0.3× 33 441

Countries citing papers authored by Tatsushi Kawada

Since Specialization
Citations

This map shows the geographic impact of Tatsushi Kawada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsushi Kawada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsushi Kawada more than expected).

Fields of papers citing papers by Tatsushi Kawada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsushi Kawada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsushi Kawada. The network helps show where Tatsushi Kawada may publish in the future.

Co-authorship network of co-authors of Tatsushi Kawada

This figure shows the co-authorship network connecting the top 25 collaborators of Tatsushi Kawada. A scholar is included among the top collaborators of Tatsushi Kawada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatsushi Kawada. Tatsushi Kawada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yanagisawa, Takafumi, Keiichiro Mori, Akihiro Matsukawa, et al.. (2025). Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis. Cancer Immunology Immunotherapy. 74(3). 76–76. 1 indexed citations
2.
Yanagisawa, Takafumi, Akihiro Matsukawa, Jeremy Yuen‐Chun Teoh, et al.. (2025). Advancements in systemic therapy for muscle-invasive bladder cancer: A systematic review from the beginning to the latest updates. Bladder Cancer. 11(2). 1802647506–1802647506. 1 indexed citations
3.
Matsumoto, Naomi, Tomoko Kobayashi, Tatsushi Kawada, et al.. (2025). Daytime Bladder Control Status in Toddlerhood Is Associated With Subsequent Bedwetting in Preschool Years: A Nationwide Cohort Study of Over 30 000 Japanese Children. International Journal of Urology. 33(1). e70288–e70288.
4.
Kidokoro, Kengo, Shotaro Nishimura, Yuki Maruyama, et al.. (2025). Adenosine-mediated Neutrophil Regulation by Dapagliflozin Attenuates Renal Ischemia/Reperfusion Injury: Real-time Imaging and Metabolic Insights. Transplantation. 110(2). e385–e394.
5.
Yanagisawa, Takafumi, Tatsushi Kawada, Kensuke Bekku, et al.. (2024). First‐line immunotherapy of metastatic renal cell carcinoma: an updated network meta‐analysis including triplet therapy. British Journal of Urology. 134(3). 323–336. 1 indexed citations
6.
Kawada, Tatsushi, Takafumi Yanagisawa, Paweł Rajwa, et al.. (2024). The Prognostic Value of Tumor Infiltrating Lymphocytes After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis. Clinical Genitourinary Cancer. 22(2). 535–543.e4. 6 indexed citations
7.
Matsukawa, Akihiro, Paweł Rajwa, Tatsushi Kawada, et al.. (2024). Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: a systematic review, meta-analysis, and network meta-analysis. International Journal of Clinical Oncology. 29(6). 716–725. 5 indexed citations
8.
Bekku, Kensuke, Tatsushi Kawada, Takuya Sadahira, et al.. (2024). Propensity score-matched analysis comparing robot-assisted partial nephrectomy and image-guided percutaneous cryoablation for cT1 renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 42(12). 453.e15–453.e22. 2 indexed citations
9.
Rajwa, Paweł, Riccardo Campi, Marcin Miszczyk, et al.. (2024). Oncological Outcomes of Active Surveillance versus Surgery or Ablation for Patients with Small Renal Masses: A Systematic Review and Quantitative Analysis. European Urology Oncology. 8(2). 544–553.
10.
Parizi, Mehdi Kardoust, Akihiro Matsukawa, Marcin Miszczyk, et al.. (2024). The efficacy of adjuvant mitotane therapy and radiotherapy following adrenalectomy in patients with adrenocortical carcinoma: A systematic review and meta-analysis. Urologic Oncology Seminars and Original Investigations. 43(5). 297–306. 1 indexed citations
11.
Yanagisawa, Takafumi, Keiichiro Mori, Akihiro Matsukawa, et al.. (2024). Updated systematic review and network meta-analysis of first-line treatments for metastatic renal cell carcinoma with extended follow-up data. Cancer Immunology Immunotherapy. 73(2). 38–38. 11 indexed citations
12.
Kawada, Tatsushi, Sung Ryul Shim, Fahad Quhal, et al.. (2023). Diagnostic Accuracy of Liquid Biomarkers for Clinically Significant Prostate Cancer Detection: A Systematic Review and Diagnostic Meta-analysis of Multiple Thresholds. European Urology Oncology. 7(4). 649–662. 16 indexed citations
13.
Bekku, Kensuke, Tatsushi Kawada, Yuki Maruyama, et al.. (2023). The Diagnosis and Treatment Approach for Oligo-Recurrent and Oligo-Progressive Renal Cell Carcinoma. Cancers. 15(24). 5873–5873. 5 indexed citations
14.
Yanagisawa, Takafumi, Paweł Rajwa, Fahad Quhal, et al.. (2023). Neoadjuvant Androgen Receptor Signaling Inhibitors before Radical Prostatectomy for Non-Metastatic Advanced Prostate Cancer: A Systematic Review. Journal of Personalized Medicine. 13(4). 641–641. 6 indexed citations
16.
Bekku, Kensuke, Manuela Schmidinger, Satoshi Katayama, et al.. (2023). Discontinuation of Immune-oncology Combinations due to Immune-related Adverse Events in Patients With Advanced Renal Cancers. Anticancer Research. 44(1). 379–386. 1 indexed citations
17.
Laukhtina, Ekaterina, Fahad Quhal, Markus von Deimling, et al.. (2023). For Which Patients Should Bladder Preservation Be Considered After a Complete Response to Neoadjuvant Chemotherapy. European Urology Focus. 9(6). 900–902. 1 indexed citations
18.
Kawada, Tatsushi, et al.. (2022). Sequential intravesical gemcitabine and docetaxel therapy in patients with nonmuscle invasive bladder cancer: a systematic review and meta-analysis. Current Opinion in Urology. 33(3). 211–218. 10 indexed citations
19.
Motlagh, Reza Sari, Takafumi Yanagisawa, Tatsushi Kawada, et al.. (2022). Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis. Prostate Cancer and Prostatic Diseases. 25(2). 187–198. 12 indexed citations
20.
Iwata, Takehiro, Yasuyuki Kobayashi, Tatsushi Kawada, et al.. (2021). Comparison of intracorporeal versus extracorporeal urinary diversion after robot-assisted radical cystectomy at a medium-sized facility. International Journal of Clinical Oncology. 26(9). 1714–1721. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026